Fundraising Fox
Helix
operating company · company profile4 people tracked
Find your way into Helix
Sign up to see every warm intro you have to Helix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Helix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Helix operates at the intersection of clinical care, research, and genomics to make genomic data practical and actionable in healthcare. The firm's mission is to empower individuals to improve their lives through DNA insights while enabling large-scale genomics initiatives. By providing an end-to-end platform, Helix aims to increase access to genetic screening, accelerate novel research, and improve healthcare outcomes through personalized medicine.
Source: firm website, verified Aug 6, 2026.
Team · 4 people
from curated & public directories
Jeffrey Bird, MD, PhD, founded and leads Bluebird Ventures and previously spent nearly 20 years as a Managing Director at Sutter Hill Ventures investing in early-stage life sciences. He has served as an investor, CEO, and board member across companies including Verinata Health, GRAIL, Forty Seven, and Portola, and earlier held a 12-year operating career at Gilead Sciences; he holds a bachelor's, MD, and PhD in Cancer Biology from Stanford.
Founder mafia
10 people who came through Helix went on to found or lead other companies.
Frequently asked questions
- What sectors does Helix focus on?
- Helix focuses on Biotech, Digital Health, Medical Devices.
Media · Podcasts & interviews
from their channelPatient Education Video
Helix
Population Genomics: Partner Perspectives - Memorial Hermann
Helix
Population Genomics: Partner Perspectives - St. Luke’s University Health Network (SLUHN)
Helix
Population Genomics: Partner Perspectives - Nebraska Medicine
Helix
Population Genomics: Partner Perspectives - Renown
Helix
Population Genomics: Partner Perspectives - Sanford Health
Helix
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.